中文名 | LCZ696中间体5 |
英文名 | 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid |
别名 | LCZ696原料 塞克比曲缬沙坦复合物 LCZ696中间体5 AHU-377(钠盐) LCZ696原研900-04 LCZ696中间体6 AHU-377 4-(((2S,4R)-1-([1,1'-联苯]-4-基)-... 4-(((2S,4R)-1-([1,1'-联苯]-4-基)-5-乙氧基-4-甲基-5-氧代戊烷-2-基)氨基)-4-氧代丁酸 4-(((2R,4S)-1-([1,1'-联苯]-4-基)-5-乙氧基-4-甲基-5-氧代戊烷-2-基)氨基)-4-氧代丁酸 |
英文别名 | AHU-37 AHU377 AHU-377 AHU 377 SACUBITRIL AHU-377,149709-62-6 (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid 4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid |
CAS | 149709-62-6 |
EINECS | 1592732-453-0 |
化学式 | C24H29NO5 |
分子量 | 411.49 |
密度 | 1.151±0.06 g/cm3(Predicted) |
沸点 | 656.9±55.0 °C(Predicted) |
溶解度 | 10毫米DMSO |
酸度系数 | 4.72±0.10(Predicted) |
存储条件 | Sealed in dry,Store in freezer, under -20°C |
体外研究 | Sacubitril (AHU-377) is a single molecule that is comprised of molecular moieties of valsartan, an ARB, and Sacubitril (AHU-377), a neprilysin inhibitor (1:1 ratio). Sacubitril (AHU-377) is converted by enzymatic cleavage of the ethyl ester into the active neprilysin inhibiting metabolite LBQ657. The inactive NEPi precursor, Sacubitril (AHU-377), does not inhibit collagen accumulation in fibroblasts nor cardiac myocyte hypertrophy. In cardiac fibroblasts, the active NEPi LBQ657 had no discernible effects. In contrast, LBQ657 modestly inhibits cardiac myocyte hypertrophy. |
体内研究 | In humans, Sacubitril (AHU-377) (t max 0.5-1.1 h) are absorbed quickly. Sacubitril (AHU-377) is converted rapidly into LBQ657 with its t max being reached in 1.9-3.5 h. Mean t 1/2 values for the biologically active LBQ657 is 9.9-11.1 h. In vehicle-treated dogs, ANF increases urinary sodium excretion from 17.3±3.6 to 199.5±18.4 pequivkglmin. This effect is potentiated significantly in animals which receive Sacubitril (AHU-377). Urinary volume is also potentiated in animals which receive an iv administration of Sacubitril (AHU-377). |
上游原料 | 原研550-06 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.43 ml | 12.151 ml | 24.302 ml |
5 mM | 0.486 ml | 2.43 ml | 4.86 ml |
10 mM | 0.243 ml | 1.215 ml | 2.43 ml |
5 mM | 0.049 ml | 0.243 ml | 0.486 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!